A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis

A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis

Abstract Nail psoriasis is a difficult-to-treat manifestation of psoriatic disease affecting up to 80% of patients with psoriatic arthritis (PsA) and 40–60% of patients with plaque psoriasis (PsO). Ixekizumab (IXE), a high-affinity monoclonal antibody that selectively targets interleukin-17A, is app...

Full description

Bibliographic Details
Main Authors: Bruce W. Kirkham, Alexander Egeberg, Frank Behrens, Andreas Pinter, Joseph F. Merola, Thorsten Holzkämper, Gaia Gallo, Khai Jing Ng, Rebecca Bolce, Christopher Schuster, Peter Nash, Luis Puig
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-07-01
Series:Rheumatology and Therapy
Subjects:
Ixekizumab
Nail psoriasis
Plaque psoriasis
Psoriatic arthritis
Online Access:https://doi.org/10.1007/s40744-023-00553-1

Internet

https://doi.org/10.1007/s40744-023-00553-1

Similar Items